Alloy Therapeutics
Drug discovery platform and services for antibody, TCR mimic, and oligonucleotide therapeutics
Funding
$136.24M
2022
Details
Headquarters
Boston, United States
CEO
Errik Anderson
Website
Milestones
FOUNDING YEAR
2017
Listed In
News
The latest coverage and announcements from Alloy Therapeutics.